MAXZIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Hydrochlorothiazide; Triamterene.
Product ID | 0378-0460_0e54ebec-df86-4205-9434-315913b56a94 |
NDC | 0378-0460 |
Product Type | Human Prescription Drug |
Proprietary Name | MAXZIDE |
Generic Name | Maxzide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1988-05-13 |
Marketing End Date | 2024-04-30 |
Marketing Category | NDA / NDA |
Application Number | NDA019129 |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
Active Ingredient Strength | 50 mg/1; mg/1 |
Pharm Classes | Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS] |
NDC Exclude Flag | N |
Marketing Start Date | 1988-05-13 |
Marketing End Date | 2024-04-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019129 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1988-05-13 |
Marketing Category | NDA |
Application Number | NDA019129 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1988-05-13 |
Marketing End Date | 2015-09-22 |
Ingredient | Strength |
---|---|
TRIAMTERENE | 75 mg/1 |
SPL SET ID: | e92eda49-861e-4c79-b446-ec1213151d92 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0378-0460 | MAXZIDE | maxzide |
0378-0464 | MAXZIDE-25 | maxzide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MAXZIDE 73483161 1376817 Live/Registered |
AMERICAN CYANAMID COMPANY 1984-06-01 |
MAXZIDE 73449182 1429786 Live/Registered |
American Cyanamid Company 1983-10-24 |